FDA Monthly Preview: Key June Decisions to Watch - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

  • By

  • Kathryn Wighton

  • May 29, 2026

  • 3 min

Share

Objective:

Revise to include the significance of the FDA decisions.

Key Findings:
  • Revise to include specific trial details and safety profiles.
Interpretation:

Remove the editorial interpretation.

Limitations:
Conclusion:

Original Source(s)

FDA Monthly Preview: Key June Decisions to Watch

  • by Kathryn Wighton

  • May 29, 2026

Related Content

CDC recommends 2026–2027 COVID vaccines for all adults

Updated guidance recommends vaccination for adults aged 18 years and older, with pediatric recommendations based on immune status.

CDC Ebola update: Outbreak outpaces 2018 surge

More than 120 CDC personnel have been deployed to affected countries as the agency responds to the world's second-largest Ebola outbreak on record.

The rationale for ophthalmic vigilance during the 2026 Hantavirus outbreak